BioSpace News Archive

Daré Bioscience, Inc., a leader in women’s health innovation, announced it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health.

ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.

Beyfortus reduced respiratory syncytial virus hospitalizations by 82% in infants under 6 months of age, compared to infants who received no RSV intervention, according to the interim results of an ongoing study published in The Lancet.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that it will host a conference call and audio webcast on Thursday, May 9, 2024 at 2:30 PM CET to discuss its first quarter 2024 financial results and provide a business update.

Verona Pharma plc, announces eight posters, including two mini oral symposia, on additional analyses from its successful Phase 3 ENHANCE studies with ensifentrine for the treatment of chronic obstructive pulmonary disease will be presented at the American Thoracic Society International Conference 2024.

Medigene AG presented superior T cell receptor engineered T cell functionality upon combination of optimal affinity 3S TCRs with the PD1-41BB costimulatory switch protein at the 7th International Neoantigen Summit held in Amsterdam, Netherlands from April 29 - May 1, 2024.

Spago Nanomedical strengthens management by the appointment of Birgitta Rembratt Svensson as Head of CMC & Supply.

Corin Group, a pioneer in orthopaedic innovation, announced the successful completion of first cases using the Apollo™ platform and ApolloKnee™ software for robotic-assisted total knee arthroplasty.

DENTSPLY SIRONA Inc. announced its financial results for the first quarter of 2024.

Drug Farm announced that the chronic hepatitis B patient data from their Phase 1b trial was accepted as a late breaking poster presentation at the 2024 European Association for the Study of the Liver conference that will be held in Milan, Italy between 05 June 2024 to 08 June 2024.